CC BY-NC-ND 4.0 · Eur J Pediatr Surg 2021; 31(01): 106-114
DOI: 10.1055/s-0040-1718750
Original Article

Gastroesophageal Reflux Disease and Need for Antireflux Surgery in Children with Cystic Fibrosis: A Systematic Review on Incidence, Surgical Complications, and Postoperative Outcomes

1   Department of Paediatric Surgery, Royal London Hospital, London, United Kingdom
,
1   Department of Paediatric Surgery, Royal London Hospital, London, United Kingdom
2   Department of Pediatric Surgery, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt (Main), Germany
,
Caroline Pao
1   Department of Paediatric Surgery, Royal London Hospital, London, United Kingdom
,
Paul Charlesworth
1   Department of Paediatric Surgery, Royal London Hospital, London, United Kingdom
› Institutsangaben

Abstract

Introduction Gastroesophageal reflux disease (GERD) is associated with accelerated decline in lung health in children with cystic fibrosis (CF). Thus, antireflux surgery (ARS) is offered to a selected CF cohort with refractory GERD, but outcomes remain poorly investigated. This study aimed to determine the incidence of GERD in children with CF and to evaluate complications and outcomes of ARS.

Materials and Methods A systematic literature-based search was conducted using various online databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The number of GERD cases in pediatric CF cohorts who underwent diagnostic investigation(s) was recorded. Data on postoperative complications and outcomes (including symptoms, lung function, and nutritional status) following ARS were analyzed.

Results Ten articles (n = 289 patients) met the defined inclusion criteria (51% male; age range, 0.5 month–36 years). The overall incidence of GERD was 46% (range, 19–81%), derived from seven studies (n = 212 patients). Four publications (n = 82 patients) reported on ARS due to uncontrolled GERD. All ARSs were Nissen fundoplication (majority with gastrostomy placement). Major postoperative complications occurred in 15 (18%) patients, two required redo-ARS. Median follow-up time was 2 years (range, 3 months–6 years); 59% showed symptom improvement, and pulmonary exacerbations and decline in lung function were reduced. Nutritional status mainly improved in milder CF cases. There were no deaths related to ARS.

Conclusion Approximately half of pediatric CF patients have GERD. Published data for children with CF are limited and heterogeneous in terms of GERD diagnosis and outcomes following ARS. However, ARS has shown to slow the deterioration of lung function in CF.



Publikationsverlauf

Eingereicht: 15. Mai 2020

Angenommen: 10. September 2020

Artikel online veröffentlicht:
17. November 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Rosen R, Vandenplas Y, Singendonk M. et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66 (03) 516-554
  • 2 Pauwels A, Decraene A, Blondeau K. et al. Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest 2012; 141 (06) 1568-1574
  • 3 Navarro J, Rainisio M, Harms HK. et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2001; 18 (02) 298-305
  • 4 Pencharz PB, Durie PR. Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr 2000; 19 (06) 387-394
  • 5 Maqbool A, Pauwels A. Cystic fibrosis and gastroesophageal reflux disease. J Cyst Fibros 2017; 16 (Suppl. 02) S2-S13
  • 6 Mauritz FA, van Herwaarden-Lindeboom MY, Stomp W. et al. The effects and efficacy of antireflux surgery in children with gastroesophageal reflux disease: a systematic review. J Gastrointest Surg 2011; 15 (10) 1872-1878
  • 7 Baerg J, Thorpe D, Gasior A, Vannix R, Tagge E, St Peter S. Factors associated with mortality after Nissen fundoplication in children. Eur J Pediatr Surg 2015; 25 (03) 277-283
  • 8 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Int J Surg 2010; 8 (05) 336-341
  • 9 OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine; Accessed August 15, 2020 at: http://www.cebm.net/index.aspx?o=5653
  • 10 Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg 2003; 73 (09) 712-716
  • 11 Vinocur CD, Marmon L, Schidlow DV, Weintraub WH. Gastroesophageal reflux in the infant with cystic fibrosis. Am J Surg 1985; 149 (01) 182-186
  • 12 Gustafsson PM, Fransson SG, Kjellman NI, Tibbling L. Gastro-oesophageal reflux and severity of pulmonary disease in cystic fibrosis. Scand J Gastroenterol 1991; 26 (05) 449-456
  • 13 Malfroot A, Dab I. New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up. Arch Dis Child 1991; 66 (11) 1339-1345
  • 14 Heine RG, Button BM, Olinsky A, Phelan PD, Catto-Smith AG. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child 1998; 78 (01) 44-48
  • 15 Brodzicki J, Trawińska-Bartnicka M, Korzon M. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis. Med Sci Monit 2002; 8 (07) CR529-CR537
  • 16 Dziekiewicz MA, Banaszkiewicz A, Urzykowska A. et al. Gastroesophageal reflux disease in children with cystic fibrosis. Adv Exp Med Biol 2015; 873: 1-7
  • 17 Hauser B, De Schepper J, Malfroot A. et al. Gastric emptying and gastro-oesophageal reflux in children with cystic fibrosis. J Cyst Fibros 2016; 15 (04) 540-547
  • 18 Bendig DW, Seilheimer DK, Wagner ML, Ferry GD, Barrison GM. Complications of gastroesophageal reflux in patients with cystic fibrosis. J Pediatr 1982; 100 (04) 536-540
  • 19 Boesch RP, Acton JD. Outcomes of fundoplication in children with cystic fibrosis. J Pediatr Surg 2007; 42 (08) 1341-1344
  • 20 Sheikh SI, Ryan-Wenger NA, McCoy KS. Outcomes of surgical management of severe GERD in patients with cystic fibrosis. Pediatr Pulmonol 2013; 48 (06) 556-562
  • 21 Jolley SG, Johnson DG, Herbst JJ, Pena A, Garnier R. An assessment of gastroesophageal reflux in children by extended pH monitoring of the distal esophagus. Surgery 1978; 84 (01) 16-24
  • 22 Martigne L, Delaage PH, Thomas-Delecourt F, Bonnelye G, Barthélémy P, Gottrand F. Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study. Eur J Pediatr 2012; 171 (12) 1767-1773
  • 23 Walker SA, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. J Pediatr Gastroenterol Nutr 1998; 27 (01) 53-56
  • 24 Cullis PS, Siminas S, Losty PD. Efficacy of antireflux surgery in children with or without neurological impairment: a systematic review. Br J Surg 2020; 107 (06) 636-646
  • 25 Cystic Fibrosis Foundation Patient Registry. 2018 Annual Data Report. 2019. Accessed August 15, 2020 at: https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2018-Patient-Registry-Annual-Data-Report.pdf